BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 204 filers reported holding BEAM THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.98 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,819,544 | +54.9% | 366,717 | +105.7% | 0.00% | 0.0% |
| Q2 2023 | $5,692,671 | -50.8% | 178,286 | -52.8% | 0.00% | 0.0% |
| Q1 2023 | $11,562,724 | +80.1% | 377,620 | +130.1% | 0.00% | 0.0% |
| Q4 2022 | $6,418,655 | +12.5% | 164,118 | +37.0% | 0.00% | 0.0% |
| Q3 2022 | $5,705,000 | +6.6% | 119,775 | -13.4% | 0.00% | 0.0% |
| Q2 2022 | $5,353,000 | -32.2% | 138,260 | +0.4% | 0.00% | 0.0% |
| Q1 2022 | $7,891,000 | -9.4% | 137,713 | +26.0% | 0.00% | 0.0% |
| Q4 2021 | $8,708,000 | +474.8% | 109,263 | +527.2% | 0.00% | – |
| Q3 2021 | $1,515,000 | -56.8% | 17,422 | -36.0% | 0.00% | – |
| Q2 2021 | $3,506,000 | +119.7% | 27,235 | +36.6% | 0.00% | – |
| Q1 2021 | $1,596,000 | +114.8% | 19,940 | +119.1% | 0.00% | – |
| Q4 2020 | $743,000 | +569.4% | 9,102 | +101.7% | 0.00% | – |
| Q3 2020 | $111,000 | -54.3% | 4,512 | -48.0% | 0.00% | – |
| Q2 2020 | $243,000 | +107.7% | 8,676 | +33.0% | 0.00% | – |
| Q1 2020 | $117,000 | – | 6,522 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |